Sharad Ghamande

4PUBLICATIONS
56CO-AUTHORS
BiomaterialsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 02, 2024
Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer.

Ana Oaknin, Sharad A Ghamande, Yuka Kasamatsu

|Jun 26, 2023
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study.

Ana Oaknin, Bhavana Pothuri, Lucy Gilbert

|May 01, 2023
Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial.

Oliver Dorigo, Amit M Oza, Tanja Pejovic

|Aug 02, 2022
Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial.

Jung-Min Lee, Richard G Moore, Sharad Ghamande

Pageof 1

Frequent Collaborators

2 joint publications

Ana Oaknin

1 joint publications

Yuka Kasamatsu

1 joint publications

Marta Gil-Martin

1 joint publications

Juan Francisco Grau-Bejar